Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Sanara Medtech stock

SMTI
US79957L1008

Price

33.51
Today +/-
+0.47
Today %
+1.53 %
P

Sanara Medtech stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Sanara Medtech stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Sanara Medtech stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Sanara Medtech stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Sanara Medtech's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Sanara Medtech Stock Price History

DateSanara Medtech Price
11/1/202433.51 undefined
10/31/202433.00 undefined
10/30/202432.75 undefined
10/29/202432.40 undefined
10/28/202432.86 undefined
10/25/202431.70 undefined
10/24/202431.55 undefined
10/23/202432.46 undefined
10/22/202433.77 undefined
10/21/202433.47 undefined
10/18/202433.29 undefined
10/17/202430.99 undefined
10/16/202431.30 undefined
10/15/202432.14 undefined
10/14/202431.87 undefined
10/11/202432.95 undefined
10/10/202431.14 undefined
10/9/202432.08 undefined
10/8/202430.96 undefined
10/7/202429.59 undefined

Sanara Medtech Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Sanara Medtech, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Sanara Medtech from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Sanara Medtech’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Sanara Medtech. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Sanara Medtech’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Sanara Medtech’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Sanara Medtech’s growth potential.

Sanara Medtech Revenue, EBIT and net profit per share

DateSanara Medtech RevenueSanara Medtech EBITSanara Medtech Net Income
2025e98.12 M undefined-7.85 M undefined-10.44 M undefined
2024e82.52 M undefined-14.59 M undefined-18.12 M undefined
202364.99 M undefined-4.22 M undefined-4.3 M undefined
202245.84 M undefined-12.04 M undefined-7.94 M undefined
202124.14 M undefined-7.38 M undefined-7.92 M undefined
202015.59 M undefined-5.04 M undefined-4.36 M undefined
201911.77 M undefined-2.74 M undefined-2.81 M undefined
20185.84 M undefined-500,000 undefined-730,000 undefined
20176.3 M undefined120,000 undefined190,000 undefined
20165.51 M undefined-270,000 undefined-680,000 undefined
20153.37 M undefined-960,000 undefined-1.61 M undefined
20142.63 M undefined-2.06 M undefined-2.51 M undefined
20131.73 M undefined-2.93 M undefined-4.15 M undefined
20121.17 M undefined-5.39 M undefined-1.85 M undefined
20112.21 M undefined-1.81 M undefined-12.74 M undefined
2010910,000 undefined-2.47 M undefined-6.64 M undefined
2009290,000 undefined-1.51 M undefined-3.02 M undefined
2008290,000 undefined-1.76 M undefined-1.77 M undefined
2007630,000 undefined-410,000 undefined-540,000 undefined

Sanara Medtech Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
200720082009201020112012201320142015201620172018201920202021202220232024e2025e
00002112356511152445648298
------50.00-100.0050.0066.6720.00-16.67120.0036.3660.0087.5042.2228.1319.51
----50.00--50.0066.6780.0083.33100.0090.9186.6787.5086.6789.06--
000010012455101321395700
0-1-1-2-1-5-2-20000-2-5-7-12-4-14-7
-----50.00-500.00-200.00-100.00-----18.18-33.33-29.17-26.67-6.25-17.07-7.14
0-1-3-6-12-1-4-2-1000-2-4-7-7-4-18-10
--200.00100.00100.00-91.67300.00-50.00-50.00----100.0075.00--42.86350.00-44.44
0.160.220.290.360.550.630.780.881.071.092.092.172.135.737.347.918.2800
-------------------
Details

Keystats

ⓘ

Revenue and Growth

The Sanara Medtech Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Sanara Medtech is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (k)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (k)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (k)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
20072008200920102011201220132014201520162017201820192020202120222023
                                 
0000.0500.050.040.520.180.830.460.736.610.4618.658.965.15
0.030.030.030.450.060.20.220.280.450.790.840.211.342.272.9978.53
80027010960000000000000
0.260.10.130.290.270.450.310.40.410.350.7100.751.152.053.554.72
000.010.240.290.340.080.010.110.020.030.030.160.610.921.10.61
0.370.130.441.041.581.040.651.211.151.992.040.978.864.4924.6120.6119.01
0.020.0100000.030.050.040.030.060.050.791.152.042.223.25
000000000001.9601.15.023.083.08
0001.51.75000000000000
004.584.110.430.340.290.240.190.140.120.051.473.14.7331.5144.93
0000000000000003.63.6
101030130601000000000000
0.030.024.615.742.240.350.320.290.230.170.182.062.265.3511.7940.4154.87
0.40.155.056.783.821.390.971.51.382.162.223.0311.129.8436.461.0273.87
                                 
0.030.030.030.040.060.070.620.810.910.970.970.2411.370.010.010.010.01
11.1714.4420.4124.9633.2735.1540.0943.8244.6245.8246.0148.36-2.0813.1845.8765.2172.86
-13-14.77-17.79-24.43-37.17-39.02-43.17-45.44-46.78-47.2-46.87-47.47-2.68-7.03-15.24-23.39-28.04
00000000000000000
00000000000000000
-1.8-0.32.650.57-3.84-3.8-2.46-0.81-1.25-0.410.111.136.616.1630.6441.8344.83
0.110.090.260.3200.210.190.210.240.330.290.120.410.490.591.432
0.280.370.511.010.91.230.510.510.60.640.620.282.233.055.4310.2210.09
0.330.0102.315.421.341.040000.010.010001.161.1
1.5101.642.150.562.231.71.590.610.411.2000000
0000000000000000580.36
2.230.472.415.796.885.013.442.311.451.382.120.412.643.546.0212.8113.77
0000.440.810.1900.011.21.201.51.50009.11
00000000000000000
000000000000.030.580.450.226.516.4
0000.440.810.1900.011.21.201.532.080.450.226.5115.52
2.230.472.416.237.695.23.442.322.652.582.121.944.723.996.2419.3229.28
0.430.175.066.83.851.40.981.511.42.172.233.0711.3310.1536.8861.1574.12
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Sanara Medtech provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Sanara Medtech's financial health and stability.

Assets

Sanara Medtech's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Sanara Medtech must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Sanara Medtech after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Sanara Medtech's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
20072008200920102011201220132014201520162017201820192020202120222023
0-1-3-6-12-1-4-2-1000-2-4-7-8-4
00000000000000023
000000000000000-50
0000000000000-1-10-3
001411020000002684
00000000000000000
00000000000000000
0-1-1-10-1-1-1-1000-2-4-4-5-3
000000000000-1-1000
0000-10000000-1-2-5-3-10
0000-100000000-1-4-2-9
00000000000000000
01100000-100000009
000000020000002800
011110120000902809
00000010100090000
00000000000000000
0000000000006-618-9-3
-0.38-1.06-1.3-1.59-0.34-1.23-1.85-1.7-1.210.41-0.230.27-3.88-5.67-5.56-6.3-3.51
00000000000000000

Sanara Medtech stock margins

The Sanara Medtech margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Sanara Medtech. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Sanara Medtech.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Sanara Medtech's sales revenue. A higher gross margin percentage indicates that the Sanara Medtech retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Sanara Medtech's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Sanara Medtech's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Sanara Medtech's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Sanara Medtech. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Sanara Medtech's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Sanara Medtech Margin History

Sanara Medtech Gross marginSanara Medtech Profit marginSanara Medtech EBIT marginSanara Medtech Profit margin
2025e87.92 %-8 %-10.64 %
2024e87.92 %-17.68 %-21.96 %
202387.92 %-6.49 %-6.62 %
202286.13 %-26.27 %-17.32 %
202190.43 %-30.57 %-32.81 %
202089.61 %-32.33 %-27.97 %
201989.72 %-23.28 %-23.87 %
201891.27 %-8.56 %-12.5 %
201787.3 %1.9 %3.02 %
201682.76 %-4.9 %-12.34 %
201573.59 %-28.49 %-47.77 %
201469.58 %-78.33 %-95.44 %
201353.76 %-169.36 %-239.88 %
201232.48 %-460.68 %-158.12 %
201163.8 %-81.9 %-576.47 %
201040.66 %-271.43 %-729.67 %
2009-113.79 %-520.69 %-1,041.38 %
2008-44.83 %-606.9 %-610.34 %
200765.08 %-65.08 %-85.71 %

Sanara Medtech Stock Sales Revenue, EBIT, Earnings per Share

The Sanara Medtech earnings per share therefore indicates how much revenue Sanara Medtech has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Sanara Medtech earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Sanara Medtech's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Sanara Medtech’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Sanara Medtech's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Sanara Medtech Revenue, EBIT and net profit per share

DateSanara Medtech Sales per ShareSanara Medtech EBIT per shareSanara Medtech Earnings per Share
2025e11.21 undefined0 undefined-1.19 undefined
2024e9.43 undefined0 undefined-2.07 undefined
20237.85 undefined-0.51 undefined-0.52 undefined
20225.8 undefined-1.52 undefined-1 undefined
20213.29 undefined-1.01 undefined-1.08 undefined
20202.72 undefined-0.88 undefined-0.76 undefined
20195.53 undefined-1.29 undefined-1.32 undefined
20182.69 undefined-0.23 undefined-0.34 undefined
20173.01 undefined0.06 undefined0.09 undefined
20165.06 undefined-0.25 undefined-0.62 undefined
20153.15 undefined-0.9 undefined-1.5 undefined
20142.99 undefined-2.34 undefined-2.85 undefined
20132.22 undefined-3.76 undefined-5.32 undefined
20121.86 undefined-8.56 undefined-2.94 undefined
20114.02 undefined-3.29 undefined-23.16 undefined
20102.53 undefined-6.86 undefined-18.44 undefined
20091 undefined-5.21 undefined-10.41 undefined
20081.32 undefined-8 undefined-8.05 undefined
20073.94 undefined-2.56 undefined-3.38 undefined

Sanara Medtech business model

Sanara Medtech Inc is a leading company specializing in the development of innovative medical devices and solutions. The company is headquartered in Texas, USA and has experienced significant growth since its founding in 2014. Its areas of specialization include wound care, incontinence management, and dermatology. The history of Sanara Medtech Inc began in 2014 when a team of experienced medical technology experts founded the company. Leveraging their extensive industry knowledge and expertise, the team quickly identified a market niche and established themselves as a leading provider of innovative solutions. The business model of Sanara Medtech Inc is focused on developing medical devices and solutions that aim to improve the daily lives of patients and healthcare professionals. The company is committed to developing and manufacturing top-quality products that contribute to enhancing patient care and supporting healthcare professionals in their tasks. Sanara Medtech Inc offers a wide range of products tailored to the needs of patients and medical professionals. Its wound care products include wound dressings, wound healing ointments, and other specialized products for treating chronic and acute wounds. The incontinence management products include disposable and reusable incontinence products designed to improve the lives of individuals with incontinence issues. Dermatology products encompass a wide range of products for treating skin conditions such as psoriasis, eczema, and rosacea, to name a few. Another focus of Sanara Medtech Inc is collaborating with private and public healthcare facilities to ensure the availability of its products in hospitals, clinics, nursing homes, and other healthcare facilities. The company also offers training and educational programs for healthcare professionals to ensure proper product use. In summary, Sanara Medtech Inc is an innovative company specializing in the development of medical devices and solutions tailored to the needs of patients and healthcare professionals. Its goal is to develop top-quality products that contribute to the improvement of healthcare and enhance the lives of patients. With a wide range of products and a strong market presence, Sanara Medtech Inc is a leading force in the medical technology industry. Sanara Medtech is one of the most popular companies on Eulerpool.com.

Sanara Medtech Revenue by Segment

  • 3 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Sanara Medtech Revenue by Segment

Segmente202320212020
Soft Tissue Repair Products54.84 M USD--
Product Sales Revenue-23.94 M USD15.39 M USD
Bone Fusion Products9.95 M USD--
Royalty Revenue-201,000 USD201,000 USD
Royalty201,000 USD--

Sanara Medtech SWOT Analysis

Strengths

Sanara Medtech Inc has a strong portfolio of innovative medical technologies and products, which gives them a competitive advantage in the market.

The company has a dedicated and experienced management team that possesses excellent expertise in the healthcare industry.

Sanara Medtech has established strong relationships with key stakeholders, including healthcare professionals, hospitals, and distributors, contributing to its market presence.

Weaknesses

The company's heavy reliance on a limited number of suppliers may expose Sanara Medtech to potential supply chain disruptions.

Sanara Medtech's current market share is relatively small compared to larger competitors, limiting its brand recognition and market reach.

The company lacks diversification in its product offerings and heavily depends on a few key products for revenue generation.

Opportunities

The growing demand for advanced wound care solutions presents significant growth opportunities for Sanara Medtech Inc.

Expansion into international markets can help Sanara Medtech to tap into new customer bases and diversify its revenue streams.

The increasing adoption of telemedicine and remote healthcare services provides an opportunity for the company to develop innovative virtual wound care solutions.

Threats

The healthcare industry is highly regulated, which poses compliance challenges for Sanara Medtech and exposes the company to legal and regulatory risks.

Intense competition from established medical technology companies and new entrants in the market may potentially erode Sanara Medtech's market share.

Economic downturns and changes in healthcare policies and reimbursement models can impact the purchasing power of healthcare providers, affecting the demand for Sanara Medtech's products.

Sanara Medtech Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Sanara Medtech historical P/E ratio, EBIT multiple, and P/S ratio

Sanara Medtech shares outstanding

The number of shares was Sanara Medtech in 2023 — This indicates how many shares 8.279 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Sanara Medtech earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Sanara Medtech's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Sanara Medtech’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Sanara Medtech's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Sanara Medtech stock splits

In Sanara Medtech's history, there have been no stock splits.

The World’s Best Investors Are On Eulerpool

Unfortunately, there are currently no price targets and forecasts available for Sanara Medtech.

Sanara Medtech latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/2024-0.21 -0.41  (-91.41 %)2024 Q2
3/31/2024-0.07 -0.21  (-194.12 %)2024 Q1
12/31/2023-0.13 -0.03  (77.38 %)2023 Q4
9/30/20230 -0.13  (0 %)2023 Q3
6/30/2023-0.13 -0.22  (-65.91 %)2023 Q2
3/31/2023-0.34 -0.14  (58.41 %)2023 Q1
12/31/2022-0.27 -0.38  (-43.29 %)2022 Q4
9/30/2022-0.33 -0.18  (44.85 %)2022 Q3
6/30/2022-0.29 -0.42  (-47.06 %)2022 Q2
12/31/2021-0.28 -0.48  (-74.29 %)2021 Q4
1
2

Eulerpool ESG Scorecard© for the Sanara Medtech stock

Eulerpool World ESG Rating (EESG©)

18/ 100

🌱 Environment

5

👫 Social

16

🏛️ Governance

34

Environment

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Sanara Medtech shareholders

%
Name
Stocks
Change
Date
40.13474 % FA Sanara, L.L.C.3,511,79004/5/2024
11.05111 % Stuckert (James W)966,9723,4406/12/2024
5.86139 % Tall Pines Capital LLC512,872512,8729/30/2024
5.60450 % Howell (Solomon Oden Jr)490,39404/5/2024
2.04309 % BlackRock Institutional Trust Company, N.A.178,770-1,0996/30/2024
1.66353 % The Vanguard Group, Inc.145,5591,1656/30/2024
1.14360 % Stonebridge Wealth Management, LLC100,065100,0659/30/2024
0.96590 % Geode Capital Management, L.L.C.84,5165,2216/30/2024
0.64581 % Nixon (Ronald T)56,50810,8126/12/2024
0.61435 % State Street Global Advisors (US)53,7562426/30/2024
1
2
3
4
5
...
10

Sanara Medtech Executives and Management Board

Mr. Zachary Fleming(48)
Sanara Medtech Chief Executive Officer
Compensation 1.1 M
Mr. Michael McNeil(58)
Sanara Medtech Chief Financial Officer
Compensation 602,355
Ms. Ann Salamone(72)
Sanara Medtech Director
Compensation 316,624
Mr. Robert DeSutter(54)
Sanara Medtech Independent Director
Compensation 177,551
Mr. Eric Tanzberger(54)
Sanara Medtech Independent Director
Compensation 169,802
1
2
3

Most common questions regarding Sanara Medtech

What values and corporate philosophy does Sanara Medtech represent?

Sanara Medtech Inc is a reputable company known for its strong values and corporate philosophy. With a customer-centric approach, they prioritize innovation, excellence, and integrity in all their operations. Sanara Medtech Inc aims to provide cutting-edge medical technologies and solutions that improve patient outcomes and quality of life. Backed by a highly skilled team and state-of-the-art research, they strive to deliver superior healthcare products and services. By fostering partnerships and collaboration, Sanara Medtech Inc demonstrates a commitment to advancing medical advancements and driving positive change in the industry. Their dedication to promoting excellence and integrity sets them apart as a leader in the healthcare sector.

In which countries and regions is Sanara Medtech primarily present?

Sanara Medtech Inc is primarily present in the United States.

What significant milestones has the company Sanara Medtech achieved?

Sanara Medtech Inc has achieved several significant milestones. The company successfully developed and commercialized its flagship product, the BIAKŌS® Antimicrobial Barrier Film, which provides advanced wound care solutions. Sanara Medtech Inc also received FDA 510(k) clearance for its BIAKŌS® Wound Gel, expanding its product portfolio. Additionally, the company formed strategic partnerships with healthcare providers and established distribution agreements to enhance market reach. Sanara Medtech Inc's dedication to innovation, regulatory compliance, and customer satisfaction has solidified its position as a leader in the medical technology industry.

What is the history and background of the company Sanara Medtech?

Sanara Medtech Inc, formerly known as Wound Management Technologies, is a Texas-based medical technology company. It specializes in developing and commercializing advanced wound care products. Established in 2014, Sanara Medtech focuses on delivering innovative solutions to address acute and chronic wounds. Their products include a range of advanced wound dressings, collagen-based dressings, and therapeutic lotions designed to promote healing and improve patient outcomes. With a dedicated team of experts and strong research and development capabilities, Sanara Medtech is committed to providing effective and reliable wound care solutions to patients and healthcare providers worldwide.

Who are the main competitors of Sanara Medtech in the market?

The main competitors of Sanara Medtech Inc in the market include companies such as Acelity, Mölnlycke Health Care, and Smith & Nephew.

In which industries is Sanara Medtech primarily active?

Sanara Medtech Inc is primarily active in the medical technology industry.

What is the business model of Sanara Medtech?

The business model of Sanara Medtech Inc focuses on developing and commercializing innovative biotechnology and medical device products. The company aims to provide advanced wound care solutions to cater to the growing needs of patients worldwide. Sanara Medtech Inc leverages its expertise in wound healing and tissue regeneration to develop cutting-edge products that enhance patient outcomes. By offering a diverse portfolio of advanced products, the company aims to address the unmet needs of healthcare professionals and improve the quality of life for patients. Sanara Medtech Inc continually strives to expand its market presence and deliver innovative solutions for wound healing and tissue repair.

What is the P/E ratio of Sanara Medtech 2024?

The Sanara Medtech P/E ratio is -15.31.

What is the P/S ratio of Sanara Medtech 2024?

The Sanara Medtech P/S ratio is 3.36.

What is the Quality Investing of Sanara Medtech?

The Quality Investing for Sanara Medtech is 4/10.

What is the revenue of Sanara Medtech 2024?

The expected Sanara Medtech revenue is 82.52 M USD.

How high is the profit of Sanara Medtech 2024?

The expected Sanara Medtech profit is -18.12 M USD.

What is the business model of Sanara Medtech

Sanara Medtech Inc. is a leading company in the field of wound care and offers innovative products and solutions for wound healing. The company is headquartered in Dallas, Texas and was founded in 2014. It specializes in providing patients and medical professionals with new products and technologies with clinically proven results. Sanara Medtech operates in three main areas: wound healing, incontinence and hygiene products, and hernia care. In the field of wound healing, the company offers a range of products specifically designed to accelerate and improve wound healing. This is achieved through the use of innovative dressing systems that regulate moisture, temperature, and oxygen levels to achieve optimal healing outcomes. In the incontinence and hygiene products sector, Sanara Medtech provides bladder and bowel incontinence management. Special absorbent pads and underpads are provided that are suitable for both men and women. The company also offers effective and skin-friendly cleansing lotions and cleaning products. In the hernia care sector, the company offers various implants and meshes. These include both new developments and standard products used for the stabilization of abdominal wall hernias. The products are surgical instruments and medical devices manufactured to the highest quality standards to achieve the best possible benefit for patients. Sanara Medtech's business model is focused on the healthcare market and aims to provide the best customer service and products in the field of wound care and medical devices. To achieve this, the company works closely with medical professionals and patient organizations. Sanara Medtech is committed to continuously improving existing products and offering innovative solutions in wound care to provide the best possible benefit for patients. Innovation, quality, and customer service are the key elements of Sanara Medtech's business model. The company relies on effective organization and coordination of all business areas, from research and development to sales. Sanara Medtech also aims to ensure sustainable economic growth through appropriate measures. In summary, Sanara Medtech Inc. is a company operating in the fields of wound healing, incontinence and hygiene products, and hernia care. The company offers innovative products and solutions of the highest quality standard and is committed to achieving the best possible benefit for patients through continuous research and development. The close partnerships with medical professionals and patient organizations enable the company to develop innovative products and provide the best possible customer service.

What is the Sanara Medtech dividend?

Sanara Medtech pays a dividend of 0 USD distributed over payouts per year.

How often does Sanara Medtech pay dividends?

The dividend cannot currently be calculated for Sanara Medtech or the company does not pay out a dividend.

What is the Sanara Medtech ISIN?

The ISIN of Sanara Medtech is US79957L1008.

What is the Sanara Medtech ticker?

The ticker of Sanara Medtech is SMTI.

How much dividend does Sanara Medtech pay?

Over the past 12 months, Sanara Medtech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Sanara Medtech is expected to pay a dividend of 0 USD.

What is the dividend yield of Sanara Medtech?

The current dividend yield of Sanara Medtech is .

When does Sanara Medtech pay dividends?

Sanara Medtech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Sanara Medtech?

Sanara Medtech paid dividends every year for the past 0 years.

What is the dividend of Sanara Medtech?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Sanara Medtech located?

Sanara Medtech is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sanara Medtech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sanara Medtech from 11/4/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/4/2024.

When did Sanara Medtech pay the last dividend?

The last dividend was paid out on 11/4/2024.

What was the dividend of Sanara Medtech in the year 2023?

In the year 2023, Sanara Medtech distributed 0 USD as dividends.

In which currency does Sanara Medtech pay out the dividend?

The dividends of Sanara Medtech are distributed in USD.

All fundamentals about Sanara Medtech

Our stock analysis for Sanara Medtech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sanara Medtech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.